Literature DB >> 7400313

Gluten-sensitive enteropathy. Influence of histocompatibility type on gluten sensitivity in vitro.

Z M Falchuk, D L Nelson, A J Katz, J E Bernardin, D D Kasarda, N E Hague, W Strober.   

Abstract

We previously developed an in vitro organ culture system in which gluten exerts a toxic effect on intestinal mucosa of patients with active gluten-sensitive enteropathy. Gluten generally inhibits the epithelial cell maturation of intestinal biopsy specimens that otherwise occurs if the tissue is cultured for 24-48 h in a gluten-free medium. However, small intestinal mucosa from 15-20% of patients with proven gluten-sensitive enteropathy fails to manifest the expected gluten-induced damage in vitro. In the present study, we explored the relation between in vitro gluten-induced intestinal damage and the presence of HLA-B8. We determined whether the patients' histocompatibility type (HLA-B8 positive or negative) influenced the ability of gluten protein to inhibit epithelial cell maturation of cultured intestinal biopsy specimens from patients with gluten-sensitive enteropathy. Intestinal biopsies from 21 of 24 patients with gluten-sensitive enteropathy and HLA-B8 showed gluten-induced damage in vitro. On the other hand, intestinal biopsies from only 4 of 16 patients with gluten-sensitive enteropathy but without HLA-B8 showed gluten-induced damage in vitro. The difference in the effect of gluten in vitro between these two groups was statistically significant (P < 0.01). The data show a dichotomy between gluten-induced tissue damage in vivo and in vitro in HLA-B8 negative patients, suggesting that HLA-B8 is important for gluten to manifest a cytotoxic influence in organ culture.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400313      PMCID: PMC371702          DOI: 10.1172/JCI109848

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.

Authors:  Z M Falchuk; R L Gebhard; C Sessoms; W Strober
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects.

Authors:  A P Douglas
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

3.  Gluten-sensitive enteropathy: synthesis of antigliadin antibody in vitro.

Authors:  Z M Falchuk; W Strober
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

4.  Histocompatibility antigens associated with adult coeliac disease.

Authors:  P L Stokes; P Asquith; G K Holmes; P Mackintosh; W T Cooke
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy.

Authors:  Z M Falchuk; G N Rogentine; W Strober
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

6.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

7.  HLA-DW3 associated with coeliac disease.

Authors:  J J Keuning; A S Peña; A van Leeuwen; J P van Hooff; J J va Rood
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

8.  An alternative mechanism for gluten toxicity in coeliac disease.

Authors:  M M Weiser; A P Douglas
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Specific B-cell antigens associated with gluten-sensitive enteropathy and dermatitis herpetiformis.

Authors:  D L Mann; S I Katz; D L Nelson; L D Abelson
Journal:  Lancet       Date:  1976-01-17       Impact factor: 79.321

10.  Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

Authors:  A Ferguson; T T MacDonald; J P McClure; R J Holden
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

View more
  11 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 2.  Food allergens.

Authors:  D D Metcalfe
Journal:  Clin Rev Allergy       Date:  1985-07

Review 3.  Organ culture of gastrointestinal mucosa--a technique for the study of the human gastrointestinal tract.

Authors:  P D Howdle
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

4.  HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects.

Authors:  M Demarchi; A Carbonara; N Ansaldi; B Santini; C Barbera; I Borelli; P Rossino; S Rendine
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

5.  The lectin properties of gluten as the basis of the pathomechanism of gluten-sensitive enteropathy.

Authors:  E Köttgen; F Kluge; B Volk; W Gerok
Journal:  Klin Wochenschr       Date:  1983-01-17

6.  In vitro diagnosis of coeliac disease: an assessment.

Authors:  P D Howdle; G R Corazza; A W Bullen; M S Losowsky
Journal:  Gut       Date:  1981-11       Impact factor: 23.059

7.  Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease.

Authors:  P D Howdle; A W Bullen; M S Losowsky
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy.

Authors:  C A Alper; E Fleischnick; Z Awdeh; A J Katz; E J Yunis
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 9.  [Gluten-sensitive enteropathy--in the light of new clinical and pathogenetic aspects].

Authors:  F Kluge; H K Koch; E Köttgen; W Gerok
Journal:  Klin Wochenschr       Date:  1983-07-15

10.  The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Authors:  H Arentz-Hansen; R Körner; O Molberg; H Quarsten; W Vader; Y M Kooy; K E Lundin; F Koning; P Roepstorff; L M Sollid; S N McAdam
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.